Adtec Clinical Data | Adtec Healthcare

Resources

Clinical data

73.5

Reduced load

Clinically proven to reduce bacterial load by 73.5%.¹

100

Size reduction

Documented reduction of up to 100% in wound size.²

100

Depth reduction

Documented reduction of up to 100% in wound depth.²

0

Reported adverse events.³

18

Years of clinical experience.³

10

K+

Treatments worldwide.³

Clinically proven to clear infection

Premium Cold Plasma was found to significantly reduce wound size and infection, proving a safe, effective, outpatient therapy for LVAD driveline infections.

Kremer et al., 2021

Premium Cold Plasma treatment is a potent, safe and painless supplemental technique to treat driveline infections without need for repeat surgical interventions.

Kremer et al., 2020

Premium Cold Plasma safely reduced bacterial load and wound size, improving healing in LVAD driveline infections without repeated surgical intervention.

Kremer et al., 2022

Treatment with Adtec’s Premium Cold Plasma is a safe, painless and effective technique to decrease the bacterial load in chronic wounds.

Isbary et al., 2012

Premium Cold Plasma improves various aspects of wound healing, such wound size, depth, and perceived pain in patients with non-healing chronic wound infections.

Moelleken et al., 2020

Premium Cold Plasma treatment may accelerate healing, significantly reducing wound width and length in chronic venous ulcers versus controls.

Isbary et al., 2013

Premium Cold Plasma improves various aspects of wound healing, such wound size, depth and perceived pain in patients with non healing chronic wound infections.

Moelleken et al., 2020

Premium Cold Plasma significantly accelerates wound healing in skin graft donor sites by promoting faster re-epithelialisation and reducing wound debris.

Heinlin et al., 2013

Highly significant (34%, P < 10(-6)) reduction of bacterial load in treated chronic wounds, regardless of the type of bacteria. No side-effects occurred and the treatment was well tolerated.

Isbary et al, 2010

01

Speak to a representative to check eligibility

Meet with our team and check if you’re eligible to evaluate.

02

Start a fully supported evaluation

Get full training, clinical support, and outcome tracking throughout.

03

Choose to lease or buy

Decide on the best funding route for your hospital.

References

1. Isbary G, Heinlin J, Shimizu T, et al. Successful and safe use of 2 min cold atmospheric argon plasma in chronic wounds: results of a randomized controlled trial. Br J Dermatol. 2012;167(2):404-410. doi:10.1111/j.1365-2133.2012.10923.x

2. Moelleken M, Jockenhöfer F, Wiegand C, Buer J, Benson S, Dissemond J. Pilot study on the influence of cold atmospheric plasma on bacterial contamination and healing tendency of chronic wounds. J Dtsch Dermatol Ges J Ger Soc Dermatol JDDG. 2020;18(10):1094-1101. doi:10.1111/ddg.14294

3. Data on file.

Clinical data

73.5

Clinically proven to reduce bacterial load by 73.5%.1

100

Documented reduction of up to 100% in wound size.2

100

Documented reduction of up to 100% in wound depth.2

0

Reported adverse events.3

18

Years of clinical experience.3

10

Treatments worldwide.3

Clinically proven to clear infection

Premium Cold Plasma was found to significantly reduce wound size and infection, proving a safe, effective, outpatient therapy for LVAD driveline infections.

Premium Cold Plasma treatment is a potent, safe and painless supplemental technique to treat driveline infections without need for repeat surgical interventions.

Premium Cold Plasma safely reduced bacterial load and wound size, improving healing in LVAD driveline infections without repeated surgical intervention.

Treatment with Adtec’s Premium Cold Plasma is a safe, painless and effective technique to decrease the bacterial load in chronic wounds.

Premium Cold Plasma improves various aspects of wound healing, such wound size, depth, and perceived pain in patients with non-healing chronic wound infections.

Premium Cold Plasma treatment may accelerate healing, significantly reducing wound width and length in chronic venous ulcers versus controls.

Premium Cold Plasma improves various aspects of wound healing, such wound size, depth and perceived pain in patients with non healing chronic wound infections.

Premium Cold Plasma significantly accelerates wound healing in skin graft donor sites by promoting faster re-epithelialisation and reducing wound debris.

Highly significant (34%, P < 10(-6)) reduction of bacterial load in treated chronic wounds, regardless of the type of bacteria. No side-effects occurred and the treatment was well tolerated.

Getting started is simple

01

Speak to a representative to check eligibility

Meet with our team and check if you’re eligible to evaluate.

02

Start a fully supported evaluation

Get full training, clinical support, and outcome tracking throughout.

03

Choose to lease or buy

Decide on the best funding route for your hospital.

References

Speak to a representative to check eligibility

Clinically proven to reduce bacterial load by 73.5%.¹

Documented reduction of up to 100% in wound size.²

Documented reduction of up to 100% in wound depth.²

Reported adverse events.³

Years of clinical experience.³

Treatments worldwide.³